Joins is a new anti-arthritic drug developed by the Life Science R&D Center of SK chemical.
Joins has a strong anti-inflammatory effect on the affected region.
Joins inhibits the degradation of proteoglycan and attenuates the osteoarthritis-like change induced by collagenase and free radicals. So, Joins has a prophylactic effect against the progression of osteoarthritis. Joins has fewer adverse effects than existing NSAIDs and so can be prescribed to older patients over a long period.